360 related articles for article (PubMed ID: 8617308)
21. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
Mukherjee R; Chaturvedi P; Lee-Chan E; Singh B
Mol Immunol; 2008 Apr; 45(8):2166-76. PubMed ID: 18279957
[TBL] [Abstract][Full Text] [Related]
22. Intracellular transport of MHC class II and associated invariant chain in antigen presenting cells from AP-3-deficient mocha mice.
Sevilla LM; Richter SS; Miller J
Cell Immunol; 2001 Jun; 210(2):143-53. PubMed ID: 11520080
[TBL] [Abstract][Full Text] [Related]
23. Invariant chain influences the immunological recognition of MHC class II molecules.
Peterson M; Miller J
Nature; 1990 May; 345(6271):172-4. PubMed ID: 1692393
[TBL] [Abstract][Full Text] [Related]
24. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.
Riberdy JM; Newcomb JR; Surman MJ; Barbosa JA; Cresswell P
Nature; 1992 Dec; 360(6403):474-7. PubMed ID: 1448172
[TBL] [Abstract][Full Text] [Related]
25. Mutation of the invariant chain transmembrane region inhibits II degradation, prolongs association with MHC class II, and selectively disrupts antigen presentation.
Frauwirth K; Shastri N
Cell Immunol; 2001 May; 209(2):97-108. PubMed ID: 11446742
[TBL] [Abstract][Full Text] [Related]
26. Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells.
Nag B; Kendrick T; Arimilli S; Yu SC; Sriram S
Cell Immunol; 1996 May; 170(1):25-33. PubMed ID: 8660796
[TBL] [Abstract][Full Text] [Related]
27. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
Singh N; Van Kaer L
J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950
[TBL] [Abstract][Full Text] [Related]
28. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
[TBL] [Abstract][Full Text] [Related]
29. Viral peptide specific induction of MHC class II expression by murine T cell clones.
Thomas DB; Smith CA; Graham CM
J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
[TBL] [Abstract][Full Text] [Related]
30. Invariant chain can bind MHC class II at a site other than the peptide binding groove.
Wilson NA; Wolf P; Ploegh H; Ignatowicz L; Kappler J; Marrack P
J Immunol; 1998 Nov; 161(9):4777-84. PubMed ID: 9794409
[TBL] [Abstract][Full Text] [Related]
31. Selectivity of the major histocompatibility complex class II presentation pathway of cortical thymic epithelial cell lines.
Oukka M; Andre P; Turmel P; Besnard N; Angevin V; Karlsson L; Trans PL; Charron D; Bihain B; Kosmatopoulos K; Lotteau V
Eur J Immunol; 1997 Apr; 27(4):855-9. PubMed ID: 9130635
[TBL] [Abstract][Full Text] [Related]
32. Soluble mouse major histocompatibility complex class II molecules produced in Drosophila cells.
Wallny HJ; Sollami G; Karjalainen K
Eur J Immunol; 1995 May; 25(5):1262-6. PubMed ID: 7774629
[TBL] [Abstract][Full Text] [Related]
33. The p35 human invariant chain in transgenic mice restores mature B cells in the absence of endogenous CD74.
Genève L; Ménard C; Labrecque N; Thibodeau J
Int Immunol; 2012 Oct; 24(10):645-60. PubMed ID: 22966065
[TBL] [Abstract][Full Text] [Related]
34. Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents.
Humbert M; Bertolino P; Forquet F; Rabourdin-Combe C; Gerlier D; Davoust J; Salamero J
Eur J Immunol; 1993 Dec; 23(12):3167-72. PubMed ID: 8258331
[TBL] [Abstract][Full Text] [Related]
35. Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.
Schlundt A; Günther S; Sticht J; Wieczorek M; Roske Y; Heinemann U; Freund C
J Mol Biol; 2012 Oct; 423(3):294-302. PubMed ID: 22820093
[TBL] [Abstract][Full Text] [Related]
36. Assembly of an abundant endogenous major histocompatibility complex class II/peptide complex in class II compartments.
Morkowski S; Raposo G; Kleijimeer M; Geuze HJ; Rudensky AY
Eur J Immunol; 1997 Mar; 27(3):609-17. PubMed ID: 9079799
[TBL] [Abstract][Full Text] [Related]
37. Nonobese diabetic mice display elevated levels of class II-associated invariant chain peptide associated with I-Ag7 on the cell surface.
Bhatnagar A; Milburn PJ; Lobigs M; Blanden RV; Gautam AM
J Immunol; 2001 Apr; 166(7):4490-7. PubMed ID: 11254705
[TBL] [Abstract][Full Text] [Related]
38. N-terminal functional region of the invariant chain efficiently targets the binding of a CTL epitope to MHC class I molecules during cross-presentation.
Wu C; Zhang DG; Chen FF; Liu XL; Liu SJ; Yu WY
Genet Mol Res; 2014 Apr; 13(2):2438-50. PubMed ID: 24781998
[TBL] [Abstract][Full Text] [Related]
39. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.
Honey K; Forbush K; Jensen PE; Rudensky AY
J Immunol; 2004 Apr; 172(7):4142-50. PubMed ID: 15034026
[TBL] [Abstract][Full Text] [Related]
40. CDw78--a determinant on a major histocompatibility complex class II subpopulation that can be induced to associate with the cytoskeleton.
Rasmussen AM; Horejsí V; Levy FO; Blomhoff HK; Smeland EB; Beiske K; Michaelsen TE; Gaudernack G; Funderud S
Eur J Immunol; 1997 Dec; 27(12):3206-13. PubMed ID: 9464807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]